Abstract:Alzheimer's disease (AD) is a chronic neurodegenerative, and abnormal aggregation of the neurotoxic β amyloid (Aβ) peptide is an early event in AD. The present study aimed to determine the correlation between the nicotinic acetylcholine receptor α7 subunit (α7 nAChR) and Aβ in the brains of patients with AD, and to investigate whether the increased expression levels of the α7 nAChR could alter the neurotoxicity of Aβ. The expression levels of α7 nAChR and Aβ in the brains of patients with AD and healthy brains were analyzed using immunofluorescence. Moreover, SH‑SY5Y cells were used to stably overexpress or silence α7 nAChR expression levels, prior to the treatment with or without 1 µmol/l Aβ1‑42 oligomer (AβO). The mRNA and protein expression levels of α7 nAChR, synaptophysin (SYP), postsynaptic density of 95 kDa (PSD‑95) and synaptosomal‑associated protein of 25 kDa (SNAP‑25) were subsequently analyzed using reverse transcription‑quantitative PCR and western blotting. In addition, the concentration of acetylcholine (ACh) and the activity of acetylcholinesterase (AChE) were analyzed using spectrophotometry, while the cell apoptotic rate was determined using flow cytometry. The expression of Aβ in the brains of patients with AD was found to be significantly increased, whereas the expression of α7 nAChR was significantly decreased compared with the healthy control group. In vitro, the expression levels of α7 nAChR were significantly increased or decreased following the overexpression or silencing of the gene, respectively. Consistent with these observations, the mRNA and protein expression levels of SYP, PSD‑95 and SNAP‑25 were also significantly increased following the overexpression of α7 nAChR and decreased following the genetic silencing of the receptor. In untransfected or negative control cells, the expression levels of these factors and the apoptotic rate were significantly reduced following the exposure to AβO, which was found to be attenuated by α7 nAChR overexpression, but potentiated by α7 nAChR RNA silencing. However, no significant differences were observed in either the ACh concentration or AChE activity following transfection. Collectively, these findings suggested that α7 nAChR may protect the brains of patients with AD against Aβ, as α7 nAChR overexpression increased the expression levels of SYP, SNAP‑25 and PSD‑95, and attenuated the inhibitory effect of Aβ on the expression of these synaptic proteins and cell apoptosis. Overall, this indicated that α7 nAChR may serve an important neuroprotective role in AD.

Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases.

Effects of statins on α7 nicotinic receptor, cholinesterase and α-form of secreted amyloid precursor peptide in SH-SY5Y cells

Stigmasterol Attenuates Inflammatory Response of Microglia Via NF-κB and NLRP3 Signaling by AMPK Activation.

Lovastatin may up-regulate expression of muscarinic acetylcholine receptors and against the neurotoxicity of β-amyloid peptide on the receptors

Influence of cholesterol and lovastatin on α-form of secreted amyloid precursor protein and expression of α7 nicotinic receptor on astrocytes

The Effect of HIV Protease Inhibitors on Amyloid-β Peptide Degradation and Synthesis in Human Cells and Alzheimer’s Disease Animal Model

Statin'S Excitoprotection Is Mediated By Sapp And The Subsequent Attenuation Of Calpain-Induced Truncation Events, Likely Via Rho-Rock Signaling

Preventing Expression of the Nicotinic Receptor Subunit α7 in SH-SY5Y Cells with Interference RNA Indicates that this Receptor may Protect Against the Neurotoxicity of Aβ

Preventing Expression Of The Nicotinic Receptor Subunit Alpha 7 In Sh-Sy5y Cells With Interference Rna Indicates That This Receptor May Protect Against The Neurotoxicity Of A Beta

Antagonism of Lovastatin on Cytotoxicity in SH-SY5Y Cells Induced by β-Amyloid Peptide Oligomers

Lovastatin Suppresses the Aberrant Tau Phosphorylation from FTDP-17 Mutation and Okadaic Acid-Induction in Rat Primary Neurons

Neuroprotective effects of β7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease

The consequences of reducing expression of the α7 nicotinic receptor by RNA interference and of stimulating its activity with an α7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

P3–349: Inhibition of Secreted Alpha–app and Enhanced Neurotoxication of Beta–amyloid Peptide by Interference of Nicotinic Receptor Alpha7 Mrna in SH–SY5Y Cells

[Neuroprotective Effects of Alpha7 Neuronal Acetylcholine Receptor and Its Roles in the Pathogenesis of Alzheimer's Disease].

Effect of Beta-Amyloid Peptides on Alpha-7 Nicotinic Receptor Status in Astrocytes and Neurons, and Its Relationship to Pathogenesis of Alzheimer's Disease

Mitochondrial Protective Mechanism of Simvastatin Protects Against Amyloidï¿½β Peptide-Induced Injury in SH-SY5Y Cells

Lovastatin Alleviates Α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy

Activation of Α7 Nicotinic Acetylcholine Receptor Alleviates Aβ1-42-induced Neurotoxicity Via Downregulation of P38 and JNK MAPK Signaling Pathways.

Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells